Stratasys (SSYS) announced it has partnered with Siemens (SIEGY) Healthineers to carry out a landmark research project designed to develop new solutions for the advancement of medical imaging phantoms for computed tomography, or CT, imaging. A tool in medical imaging and an almost universal resource in hospitals worldwide, CT phantoms are specialized devices used to evaluate and ensure the performance of CT scanners. Designed to simulate certain characteristics of the human body, phantoms enable the assessment of various core metrics, including radiation dose and image quality, aiding calibration and safeguarding consistent scanner performance. The joint development leverages Stratasys’ PolyJet technology in combination with its unique RadioMatrix technology, and Siemens Healthineers’ advanced algorithm aimed at translating scanned patient images into specific material characteristics with radiopacity of human anatomy. The solution will allow for tailored phantom manufacturing and the creation of ultra-realistic human anatomy characteristics with complete radiographic accuracy of patient-specific pathology not previously possible.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SSYS:
- Stratasys price target lowered to $15 from $17 at Lake Street
- Stratasys (NASDAQ:SSYS) Drops after Announcing Q3 Numbers
- Stratasys cuts FY23 EPS view to 10c-14c from 12c-24c, consensus 18c
- Stratasys reports Q3 EPS 4c, consensus 3c
- Options Volatility and Implied Earnings Moves Today, November 16, 2023